IN THIS EPISODE - What a peptide actually is, and why your GLP-1 is NOT the same thing as BPC-157 or TB-500 - The seven peptides the FDA is reviewing: BPC-157, KPV, TB-500 (the "Wolverine complex"), MOTS-c, DSIP, Semax, and Epitalon - The "funding gap" why peptides that can't be patented never get human clinical trials - Six things the FDA worries about in an unlabeled vial, from identity and purity to the cancer/angiogenesis risk - The two questions that tell you if a peptide provider is legitimate (503A/B pharmacies and third-party certificates of analysis) ABOUT THE GUEST Tanna Donalson is a Physician Assistant and Owner of Redbud Medical in Denver Colorado
What to look for: Probiotics that don't add prebiotic fibers (which can increase stomach pressure via gas) Lower CFU options if you're prone to reflux flare-ups Saccharomyces boulardii in some cases, if you're also having loose stools A useful mindset: if reflux is your main problem, prioritize GLP-1-specific behavior strategies (smaller meals, lower-fat meals, not lying down after eating, and discussing medication timing or dose escalation with your prescriber)
These are known as CYP2D6 inhibitors
2021 Cytochrome P450 interactions are critical in managing combined therapies, particularly in multi-drug regimens and those including agents like erlotinib, imatinib, and others known to affect CYP450 enzymes
Others linger
You can get your daily dose of MSM in our Skin Perfecting Complex
